Former Member, Scientific Advisory Group
Professor Christopher Reid is a cardiovascular epidemiologist and Associate Director of the Monash Centre of Cardiovascular Research and Education in Therapeutics. He holds a National Health and Medical Research Council Senior Research Fellowship in addition to being a Chief Investigator on both NHMRC Project and Program Grants focusing on cardiovascular disease prevention. His major research interests include clinical outcome registries, randomised trials and epidemiological studies. He has been Study Director for the 2nd Australian National Blood Pressure (ANBP2) Study and currently a Chief Investigator for the Aspirin in Reducing Events in the Elderly (ASPREE) Study and the Australian Arms of the HOPE-3, REACH and CLARIFY Registries. He is a Principal Investigator for the Victorian Cardiac Procedures Registry Project and the Melbourne Interventional Group (MIG) registries. Prof Reid has more than 300 publications, with over 200 peer-reviewed journal articles, many of which are in leading journals including the New England Journal of Medicine, Lancet, JAMA and the BMJ. He acts as Chair of the Data Safety and Monitoring Committees for a number of international clinical trials and participates as a WHO consultant for prevention of cardiovascular disease in Mongolia, Vietnam and the West Pacific region. Prof. Christopher Reid joined the SEACO Scientific Advisory Group in 2014.